These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance. Mowla R; Wang Y; Ma S; Venter H Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187 [TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV mBio; 2020 Jun; 11(3):. PubMed ID: 32487753 [TBL] [Abstract][Full Text] [Related]
7. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052 [TBL] [Abstract][Full Text] [Related]
9. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747 [TBL] [Abstract][Full Text] [Related]
10. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Alenazy R Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807 [TBL] [Abstract][Full Text] [Related]
11. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576 [TBL] [Abstract][Full Text] [Related]
12. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Rieg S; Huth A; Kalbacher H; Kern WV Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144 [TBL] [Abstract][Full Text] [Related]
14. Characterization of all RND-type multidrug efflux transporters in Vibrio parahaemolyticus. Matsuo T; Nakamura K; Kodama T; Mikami T; Hiyoshi H; Tsuchiya T; Ogawa W; Kuroda T Microbiologyopen; 2013 Oct; 2(5):725-42. PubMed ID: 23894076 [TBL] [Abstract][Full Text] [Related]
15. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors. Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653 [TBL] [Abstract][Full Text] [Related]
16. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Sugawara E; Nikaido H Antimicrob Agents Chemother; 2014 Dec; 58(12):7250-7. PubMed ID: 25246403 [TBL] [Abstract][Full Text] [Related]
17. Structures and Efflux Mechanisms of the AcrAB-TolC Pump. Yu Z; Shi X; Wang Z Subcell Biochem; 2024; 104():1-16. PubMed ID: 38963480 [TBL] [Abstract][Full Text] [Related]